Maternus-Kliniken Aktiengesellschaft (F:MAK) — Market Cap & Net Worth
Market Cap & Net Worth: Maternus-Kliniken Aktiengesellschaft (MAK)
Maternus-Kliniken Aktiengesellschaft (F:MAK) has a market capitalization of $20.47 Million (€17.51 Million) as of June 17, 2026. Listed on the F stock exchange, this Germany-based company holds position #25065 globally and #2168 in its home market, demonstrating a -0.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Maternus-Kliniken Aktiengesellschaft's stock price €0.84 by its total outstanding shares 20970000 (20.97 Million). Review Maternus-Kliniken Aktiengesellschaft (MAK) financial obligations to assess the company's total debt and financial obligations.
Maternus-Kliniken Aktiengesellschaft Market Cap History: 2015 to 2026
Maternus-Kliniken Aktiengesellschaft's market capitalization history from 2015 to 2026. Data shows change from $32.17 Million to $20.47 Million (-5.62% CAGR).
Maternus-Kliniken Aktiengesellschaft Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Maternus-Kliniken Aktiengesellschaft's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.29x
Maternus-Kliniken Aktiengesellschaft's market cap is 0.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $32.17 Million | $123.27 Million | $2.36 Million | 0.26x | 13.64x |
| 2016 | $31.60 Million | $124.04 Million | $1.10 Million | 0.25x | 28.62x |
| 2017 | $56.09 Million | $127.14 Million | -$1.46 Million | 0.44x | N/A |
| 2018 | $42.90 Million | $124.28 Million | -$1.57 Million | 0.35x | N/A |
| 2019 | $46.83 Million | $124.43 Million | -$10.26 Million | 0.38x | N/A |
| 2020 | $100.52 Million | $114.30 Million | -$9.62 Million | 0.88x | N/A |
| 2021 | $117.19 Million | $111.44 Million | -$2.48 Million | 1.05x | N/A |
| 2022 | $39.23 Million | $106.70 Million | -$14.08 Million | 0.37x | N/A |
| 2023 | $68.15 Million | $102.31 Million | -$14.26 Million | 0.67x | N/A |
| 2024 | $33.34 Million | $114.00 Million | -$13.16 Million | 0.29x | N/A |
Competitor Companies of MAK by Market Capitalization
Companies near Maternus-Kliniken Aktiengesellschaft in the global market cap rankings as of June 17, 2026.
Key companies related to Maternus-Kliniken Aktiengesellschaft by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1003 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1050 globally with a market cap of $25.53 Billion USD ( €21.84 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1333 globally with a market cap of $19.50 Billion USD ( RM77.67 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $396.93 |
| #1003 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1050 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.53 Billion | €38.77 |
| #1333 | IHH Healthcare Bhd | KLSE:5225 | $19.50 Billion | RM8.79 |
Maternus-Kliniken Aktiengesellschaft Historical Marketcap From 2015 to 2026
Between 2015 and today, Maternus-Kliniken Aktiengesellschaft's market cap moved from $32.17 Million to $ 20.47 Million, with a yearly change of -5.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €20.47 Million | -13.92% |
| 2025 | €23.78 Million | -28.68% |
| 2024 | €33.34 Million | -51.08% |
| 2023 | €68.15 Million | +73.75% |
| 2022 | €39.23 Million | -66.53% |
| 2021 | €117.19 Million | +16.59% |
| 2020 | €100.52 Million | +114.66% |
| 2019 | €46.83 Million | +9.14% |
| 2018 | €42.90 Million | -23.51% |
| 2017 | €56.09 Million | +77.50% |
| 2016 | €31.60 Million | -1.75% |
| 2015 | €32.17 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Maternus-Kliniken Aktiengesellschaft was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.47 Million USD |
| MoneyControl | $20.47 Million USD |
| MarketWatch | $20.47 Million USD |
| marketcap.company | $20.47 Million USD |
| Reuters | $20.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Maternus-Kliniken Aktiengesellschaft
Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes in Germany. The company offers senior living and care facilities, rehabilitation clinics, and specialized services in geriatric care and rehabilitation medicine. It also provides emergency call, assisted living, and follow-up treatment services, as well as fully inpatient care, outpatient care, and home emergency call serv… Read more